logo
Trippy liquid 'fireworks' appear when scientists try to mix unmixable fluids

Trippy liquid 'fireworks' appear when scientists try to mix unmixable fluids

Yahoo2 days ago
When you buy through links on our articles, Future and its syndication partners may earn a commission.
These mysterious "fireworks" aren't lighting up the night sky — they're computer simulations from a recent paper on mixing fluids that don't want to mix.
Researchers mapped out how two immiscible fluids (two fluids that do not mix, like oil and water) with different viscosities can create "fingers" when they interact. They created different patterns by alternately injecting the fluids at the center of each "firework," allowing the fluids to spread out.
Studying this phenomenon is important for storing carbon from the atmosphere in the ground, a strategy for tackling climate change. Carbon dioxide is responsible for about 80% of all heating from human-caused greenhouse gases since 1990. Removing large amounts of carbon dioxide from the atmosphere is possible, but it still has to go somewhere. Storing it in the ground is one option — and understanding fluid interactions can help us figure out how to do that.
In this case, the word "fluid" can refer to both gases and liquids, including gaseous carbon dioxide. Viscosity is a measure of how easily a fluid moves. Fluids with high viscosity move sluggishly, like molasses or tar, while low-viscosity fluids move faster and can spread out more, like water or air.
The fluid "fireworks" are caused by Saffman-Taylor instability — a phenomenon that occurs when two immiscible fluids with different viscosities are confined in a small space. When a less viscous fluid is added to the system, there aren't a lot of places for it to go, so it pushes against the thicker fluid instead — forming the distinctive patterns.
If you've ever put a drop of glue between two flat surfaces, then changed your mind and pulled them apart, you might have noticed the wet glue forming strange ridges and channels. This is Saffman-Taylor instability in action. When you pulled the pieces apart, air tried to go where the more viscous glue was and left those patterns behind.
Related: Why does nearly all life breathe oxygen?
Storing carbon dioxide in the ground involves "injecting" carbon dioxide gas into a more viscous liquid (water) in confined spaces underground, leading to Saffman-Taylor instability. The "fireworks" from the paper show that the number and extent of the fingers can be changed depending on when and how the fluid is injected into the system. Increasing the fingering effect helps keep the gas from escaping back into the atmosphere.
RELATED STORIES
—Inside the 20-year quest to unravel the bizarre realm of 'quantum superchemistry'
—Scientists just got 1 step closer to creating a 'superheavy' element that is so big, it will add a new row to the periodic table
—Chemists broke a 100-year-old rule to make extremely unstable molecules
People across the globe are already working on carbon sequestration (storage) projects — as of 2024, there were 50 facilities in operation, 44 being built, and an additional 534 in development according to the Global CCS (carbon capture and storage) Institute. Developing this technology further gives us more tools to rein in global heating caused by the presence of too much carbon dioxide in Earth's atmosphere.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Long COVID Gene Variants: A Step Toward a Diagnostic Test?
Long COVID Gene Variants: A Step Toward a Diagnostic Test?

Medscape

time5 minutes ago

  • Medscape

Long COVID Gene Variants: A Step Toward a Diagnostic Test?

A large-scale global study has identified genetic variants that are risk factors for long COVID, a discovery that helps researchers better understand the biological systems involving the disease and one small, early step toward the elusive goal of developing a long COVID diagnostic test. International researchers with the Long COVID Host Genetics Initiative used data from 33 independent studies and 19 countries across North America, Europe, the Middle East, and Asia to analyze the genomes of nearly 16,000 patients with long COVID, representing populations from six genetic ancestries. Nearly 1.9 million controls were included in the genome-wide association study, a research method that scans complete sets of DNA to identify genetic variations associated with a specific trait or disease. Genetic variants found in the FOXP4 gene had a statistically significant risk linked to long COVID, the study, published in Nature Genetics , found. The FOXP4 gene is known to impact lung function, and its expression levels were higher in those with long COVID than in controls. In addition, the risk variants had a consistent effect across different ancestries. The researchers also found a causal relationship between a SARS-CoV-2 infection and long COVID and an additional causal risk between infections severe enough to require hospitalization and long COVID. Researchers also analyzed possible connections between variants associated with long COVID and those linked to other diseases and conditions. Scientists said the overall findings provided evidence that was consistent with long COVID research that suggests both individual genetic variants and environmental risk factors contribute to disease risk. The findings also provide genetic proof linking abnormal lung physiology and the development of long COVID, the authors concluded; however, they noted that long COVID symptoms are not only limited to lung function and may include fatigue and cognitive dysfunction as well. The study's co-author, Hanna Ollila, PhD, with the Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland, underscored that the newly discovered genetic variants were not predictive for clinical tests or personal disease risk. 'The findings from our study, and from genome-wide association studies in general, tell about biological mechanisms behind a disease. This can then help to understand the disease better. For example, is it a disease neuronal, immune, metabolic, and so on?' said Ollila, who is also a researcher with the Department of Anesthesia and Center for Genomic Medicine at Massachusetts General Hospital, Boston. There are still many steps between these types of discoveries and the development of a diagnostic test, she explained, since these types of genetic variants do not function like high-impact variants such as the BRCA mutations in breast cancer. 'In other words, they do not strongly predict whether someone will develop long COVID at the individual level,' Ollila said. 'Instead, they highlight the biological systems involved in the disease. In this case, our findings point to immune pathways related to lung function.' Ollila explained that genetics can guide diagnostic development by pointing to underlying mechanisms, which may then help identify biomarkers in blood or other tissues. These biomarkers could eventually contribute to diagnostic tools, but it is a process that takes time and collaboration and often depends on progress across several fields of research including imaging and clinical phenotyping. Researchers hope that when larger sample sizes become available for bigger studies, the analyses and understanding of the correlations will become more precise, bringing more understanding and clarity on genetic risk factors, biological mechanisms, and biomarkers that could someday help with disease diagnosis. 'We are likely still several years away, and possibly even a decade or more, from having a clinically useful diagnostic test based on genetic or biological markers for long COVID,' said Ollila. 'That said, progress is accelerating thanks to the growing number of well-characterized cohorts and international collaborations. While these genetic findings are not yet ready for clinical application, they are an important step toward understanding long COVID, its relationship with other diseases, and the disease mechanisms that modulate risk for long COVID.'

Are Preschoolers in the US Meeting Healthy Behavior Goals?
Are Preschoolers in the US Meeting Healthy Behavior Goals?

Medscape

time2 hours ago

  • Medscape

Are Preschoolers in the US Meeting Healthy Behavior Goals?

TOPLINE: Only about 20% of preschoolers in the US followed five to six healthy habits, with clear differences by socioeconomic factors and geographic location. Children who lived in homes with enough food, had safe neighborhoods, had parents with excellent or very good mental health, and often ate meals with their families were more likely to have healthy behaviors. METHODOLOGY: Researchers analyzed data from the 2021 and 2022 National Survey of Children's Health to assess factors related to healthy behavior among children aged 3-5 years in the US. A total of 23,123 children were included in the analysis, with data collected through parent or caregiver reports. Six healthy behaviors were examined: daily consumption of fruits, daily consumption of vegetables, no sugary drinks, frequent outdoor play, limited screen time, and adequate sleep. Logistic regression modeling was used to assess relationships between healthy behaviors and various characteristics of the child, family, and community. TAKEAWAY: The prevalence of healthy behaviors among preschoolers varied, with 32.4% not consuming sugary drinks and 65.3% consuming fruit daily. Only 20.3% of preschoolers engaged in five to six healthy behaviors. Black non-Hispanic, Hispanic, and Asian non-Hispanic children were less likely to engage in five to six healthy behaviors than White non-Hispanic children (adjusted prevalence rate ratio [aPRR], 0.38, 0.57, and 0.64, respectively; P < .05 for all). Children aged 3 years were more likely to engage in five to six healthy behaviors than those aged 5 years. Engagement in five to six healthy behaviors was more likely among children with parents with excellent or very good mental health (aPRR, 1.30), those living in safe neighborhoods (aPRR, 1.17), those living in homes with enough food (aPRR, 1.35), and those who ate meals with their families 4 or more days a week (aPRR, 1.70; P < .05 for all). State-level variations were substantial, with Vermont having the highest adjusted prevalence of preschoolers engaging in five to six healthy behaviors (36.2%) and Mississippi, the lowest (8.3%). IN PRACTICE: 'Study findings underscore the importance of the family context and the challenges families experience in supporting children's engagement in HBs [healthy behaviors], with fewer than half of preschoolers having no sugary beverages, limited screen time, or eating vegetables daily,' wrote the authors of the study. 'There are opportunities to promote healthy living among children across multiple domains of influence, including direct counseling, screening, and referral to community resources to meet basic needs, and supporting family-focused policies and programs,' they added. SOURCE: The study was led by Julie F. Donney, PhD, of the Office of Epidemiology and Research at the Maternal and Child Health Bureau, Health Resources and Services Administration in Rockville, Maryland. It was published online on July 14, 2025, in the American Journal of Preventive Medicine. LIMITATIONS: The design of the study made it difficult to determine if healthy behaviors were caused by certain factors. The link between family or community factors and healthy behaviors may be affected by unmeasured variables such as parenting styles or seasonal changes. Different definitions of healthy behaviors were not examined. DISCLOSURES: This study did not receive any specific funding. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Point-of-Care Testing Cuts Antibiotic Use in Pharyngitis
Point-of-Care Testing Cuts Antibiotic Use in Pharyngitis

Medscape

time2 hours ago

  • Medscape

Point-of-Care Testing Cuts Antibiotic Use in Pharyngitis

TOPLINE: Point-of-care testing for group A beta-hemolytic Streptococcus (Strep A) significantly reduced antibiotic prescriptions in children and adults with signs of pharyngitis, even when used as the sole intervention. METHODOLOGY: Researchers performed a meta-analysis of eight randomized controlled trials conducted between 2007 and 2021, evaluating point-of-care testing for Strep A vs standard care. The analysis included 4249 children and adults with pharyngitis, cough, or sore throat who underwent point-of-care testing for Strep A either alone or alongside other interventions. Primary outcomes were the impacts on antibiotic prescriptions, clinical decisions, and patient health outcomes. Secondary endpoints assessed diagnostic accuracy of Strep A testing, including sensitivity and specificity measurements. TAKEAWAY: Point-of-care testing reduced antibiotic prescriptions by 38% compared with standard care (risk ratio [RR], 0.62; P < .0001) and by 41% when it was the sole intervention (RR, 0.59; P < .001). The implementation of point-of-care testing also led to a reduction in inappropriate antibiotic prescriptions (RR, 0.45; 95% CI, 0.31-0.97; P = .038). However, there were no significant differences in the patient health outcomes, such as days until pain resolution and days of school/work missed, the use of ancillary testing, or other medications such as analgesics with point-of-care testing. The reported diagnostic accuracy of Strep A point-of-care testing showed sensitivity ranging from 65% to 94% and specificity from 85% to 94%. IN PRACTICE: 'Physicians can therefore use Strep A POCTs [point-of-care tests] to inform their decisions on antibiotic prescribing without compromising patient health outcomes. In clinical practice, physicians must be aware of the limitations of Strep A POCTs, in particular, the limited sensitivity for detecting GAS [group A beta-hemolytic Streptococcus],' the authors of the study wrote. SOURCE: This study was led by Ann-Sophie Mägdefrau and Carolin Kathner-Schaffert, Jena University Hospital and InfectoGnostics Research Campus Jena, both in Jena, Germany. It was published online on July 9, 2025, in Open Forum Infectious Diseases. LIMITATIONS: High statistical heterogeneity in the meta-analyses limited the precision of the pooled effect estimates. Only three trials reported patient health outcomes, restricting evaluation of the effect of Strep A point-of-care tests on measures like recovery time. Additionally, none of the trials were blinded, introducing potential bias — particularly in evaluating subjective outcomes like pain and symptom resolution. DISCLOSURES: This study received funding from the German Federal Ministry of Education and Research. The authors reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store